DEVELOPMENT AND VALIDATION OF AN SCFV SPECIFIC FOR HUMAN GLYPICAN-3 FOR THERAPY OF HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Li, Yonghai [2 ]
Zhao, Aizhi [2 ]
Li, Hong [2 ]
Adeyemo, Oluwasayo [2 ]
Elkin, Daniel [2 ]
Scholler, Nathalie [2 ]
Kaplan, David E. [1 ,2 ]
机构：
[1] Philadelphia Vet Adm, Med Ctr, Philadelphia, PA USA
[2] Univ Penn, Philadelphia, PA 19104 USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1799
引用
收藏
页码：1135A / 1135A
页数：1
相关论文
共 50 条
  • [1] In vitro validation of human glypican-3 specific chimeric antigen receptors for hepatocellular carcinoma
    Li, Yonghai
    Kaplan, David E.
    HEPATOLOGY, 2014, 60 : 870A - 870A
  • [2] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Yao, Min
    Pan, Liu-Hong
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 122 - 123
  • [3] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Min Yao
    Liu-Hong Pan
    Deng-Fu Yao
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 122 - 123
  • [4] Upregulation of Glypican-3 in Human Hepatocellular Carcinoma
    Beppu, Tetsuya
    Suzuki, Masahiro
    Sugimoto, Kazushi
    Tanaka, Junnichiro
    Tameda, Masahiko
    Inagaki, Yuji
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Yamamoto, Norihiko
    Uchida, Kazuhiko
    Takase, Koujiro
    Shiraki, Katsuya
    GASTROENTEROLOGY, 2012, 142 (05) : S972 - S972
  • [5] Glypican-3 is overexpressed in human hepatocellular carcinoma
    Sung, YK
    Hwang, SY
    Park, MK
    Farooq, M
    Han, IS
    Bae, HI
    Kim, JC
    Kim, M
    CANCER SCIENCE, 2003, 94 (03): : 259 - 262
  • [6] Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
    Couzinet, Arnaud
    Suzuki, Toshihiro
    Nakatsura, Tetsuya
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (10) : 895 - 909
  • [7] Validation study of the prognostic immunohistochemical marker glypican-3 in hepatocellular carcinoma
    Borght, Sara Vander
    Cornelis, Tineke
    Libbrecht, Louis
    Tommaso, Luca Di
    Roncalli, Massimo
    Raskams, Tania
    HEPATOLOGY, 2007, 46 (04) : 398A - 399A
  • [8] Up-regulation of Glypican-3 in Human Hepatocellular Carcinoma
    Suzuki, Masahiro
    Sugimoto, Kazushi
    Tanaka, Junichiro
    Tameda, Masahiko
    Inagaki, Yuji
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Beppu, Tetsuya
    Yoneda, Kentaro
    Yamamoto, Norihiko
    Ito, Masaaki
    Yoneda, Misao
    Uchida, Kazuhiko
    Takase, Koujiro
    Shiraki, Katsuya
    ANTICANCER RESEARCH, 2010, 30 (12) : 5055 - 5061
  • [9] Sorafenib encapsulated in nanocarrier functionalized with glypican-3 specific peptide for targeted therapy of hepatocellular carcinoma
    Feng, Shuo
    Zhou, Juan
    Li, Zhao
    Appelman, Henry D.
    Zhao, Lili
    Zhu, Jiye
    Wang, Thomas D.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2019, 184
  • [10] Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy
    Yao, Min
    Wang, Li
    Dong, Zhizhen
    Qian, Qi
    Shi, Yun
    Yu, Dandan
    Wang, Shiye
    Zheng, Wenjie
    Yao, Dengfu
    TUMOR BIOLOGY, 2014, 35 (06) : 5857 - 5868
12345